Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Johnson & Johnson (JNJ) vs Kaltura Inc (KLTR) Price & Performance

Johnson & JohnsonTrade
Kaltura IncTrade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs Kaltura Inc — how do they compare? Johnson & Johnson trades at $260.82 (market cap $626.09B), while Kaltura Inc trades at $1.58 (market cap $249.42M). The key difference: Johnson & Johnson is far larger — about 2510.2× Kaltura Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals.

JNJKLTR
Market Cap
$626.09B$249.42M
Volume
6,156,228
Sector
HealthTechnology
52-Week High
$267.24$1.89
52-Week Low
$172.78$1.08
Enterprise Value
$654.37B$261.64M
Dividend Yield
2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.

Kaltura Inc

KLTR trades at $1.59, down 3.05% today, with a bullish technical signal from moving averages and strong institutional recognition for its AI-driven digital experience platform. Revenue is stable around $181M annually, but the company remains unprofitable, with a net income margin of -6.92% in 2026. Recent earnings beats and multiple industry awards highlight operational progress amid high valuation multiples like EV/EBITDA of 336.29.

The outlook is cautiously optimistic due to consistent revenue and margin improvements, but persistent losses and high debt pose risks. Analyst sentiment is mixed with a 44.45% buy rating, suggesting potential upside if profitability is achieved, though investor caution is warranted given the negative cash flow and insider selling activity.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ

About Kaltura Inc

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)

Read more on KLTR